专家文章 | 吴登强

搜索
登录

热心肠智库专家文章 | 吴登强

2023

FAHeterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy Model

IJMS, 10.3390/ijms242115911

CAHybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial

AJG, 10.14309/ajg.0000000000002255

CAIndependent Signaling of Hepatoma Derived Growth Factor and Tumor Necrosis Factor-Alpha in Human Gastric Cancer Organoids Infected by Helicobacter pylori

IJMS, 10.3390/ijms24076567

2022

CACut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low?

Gut, 10.1136/gutjnl-2022-329253

CACut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low?

Gut, 10.1136/gutjnl-2022-329253

CACut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low?

Gut, 10.1136/gutjnl-2022-329253

CABiomarkers of Cancer Stem Cells for Experimental Research and Clinical Application

Journal of Personalized Medicine, 10.3390/jpm12050715

FAMultiple oxidative and advanced oxidative modifications of hemoglobin in gastric cancer patients measured by nanoflow LC-MS/MS

CLIN CHIM ACTA, 10.1016/j.cca.2022.03.023

CAGeneration of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research

Cells, 10.3390/cells11020184

CAGeneration of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research

Cells, 10.3390/cells11020184

CAGeneration of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research

Cells, 10.3390/cells11020184

CAGeneration of Human Stomach Cancer iPSC-Derived Organoids Induced by Helicobacter pylori Infection and Their Application to Gastric Cancer Research

Cells, 10.3390/cells11020184

2021

CATetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection

HELICOBACTER, 10.1111/hel.12840

CAThe impact of urine microbiota in patients with lower urinary tract symptoms

ACMA, 10.1186/s12941-021-00428-9

2020

CAEquivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection

J GASTROEN HEPATOL, 10.1111/jgh.15034

2019

CATaiwan nutritional consensus on the nutrition management for gastric cancer patients receiving gastrectomy

Taiwan yi zhi, 10.1016/j.jfma.2019.11.014

CAHepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis

Oncogene, 10.1038/s41388-019-0886-3

CAGastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection

HELICOBACTER, 10.1111/hel.12568

Reply

2018

CAFecal microbiota transplantation: Review and update

Taiwan yi zhi, 10.1016/j.jfma.2018.08.011